Purchase Order 75N95021P00221

Award Date 5/6/21
Potential Completion Date 6/30/21
Potential Value $445K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Bio-Techne Corporation
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55413, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,250.50 firm fixed price purchase order to Research And Diagnostic Systems, Inc., doing business as R&D Systems, a division of Bio-Techne Corporation. The contract is for research and development reagents to be delivered from October 17, 2023 through November 6, 2023. As the prime contractor, R&D Systems will provide laboratory supplies and materials to support the NIH Clinical Center's...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,672.20 firm fixed price purchase order to Research And Diagnostic Systems, Inc., doing business as R&D Systems, a division of Bio-Techne Corporation. The contract is for the delivery of recombinant human NT-3 protein to support the agency's research efforts. As the prime contractor, R&D Systems will provide the requested products from its...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), to Research And Diagnostic Systems, Inc. (R&D Systems) for the delivery of ELISA kits. The award has a potential value of $9,237.00 and was set aside for small businesses. R&D Systems is a for-profit manufacturer of research products, including proteins, antibodies, and assay kits, and is part of the Bio-Techne Corporation. This order...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Research And Diagnostic Systems, Inc. (R&D Systems), a manufacturer and supplier of research reagents and instruments. The contract has a ceiling value of $14,595.00 and is for the delivery of recombinant human proteins. R&D Systems is a division of Bio-Techne Corporation, a leading...
The U.S. National Institutes of Health (NIH) awarded a $10,908.09 firm fixed-price purchase order to Research And Diagnostic Systems, Inc. (R&D Systems), doing business as R&D Systems, a manufacturer and supplier of research reagents and instruments. The award is for the provision of a variety of biological supplies, reagent kits, recombinant proteins, and laboratory instrumentation to support biomedical investigations, including studies related to COVID-19 and other infectious diseases,...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $24,045.00 firm fixed price purchase order to Research And Diagnostic Systems, Inc. (R&D Systems) for custom protein development services. R&D Systems is a for-profit manufacturer of antibodies, ELISA kits, proteins, and other research materials that has provided a range of products and services to various HHS agencies, including the NIH, Centers...
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases to Research And Diagnostic Systems, Inc., doing business as R&D Systems. The firm-fixed-price purchase order, valued at $222,038.00, is for the provision of medical and surgical instruments, equipment, and supplies. R&D Systems is a for-profit manufacturer and global leader in research proteins, antibodies, and...
This is a $9,325.35 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Research And Diagnostic Systems, Inc. (doing business as R&D Systems), a manufacturer of research reagents and instruments. The contract is for the delivery of unspecified research and development (R&D) systems, with a period of performance ending on July 31, 2019. R&D Systems has provided similar supplies and services to various NIH institutes in the...
This is a $11,295.00 firm fixed price purchase order awarded to Research And Diagnostic Systems, Inc. (R&D Systems) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract is for the provision of recombinant human proteins and antibodies, which are essential research reagents used in studies of infectious diseases, cancer, and other health conditions. R&D Systems is a subsidiary of the parent...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Research And Diagnostic Systems, Inc. (R&D Systems), doing business as R&D Systems. The $14,081.90 contract is for the delivery of recombinant protein and has a total small business set-aside designation. R&D Systems is a manufacturer of research materials including proteins,...

This purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Research and Diagnostic Systems, Inc. is valued at $445,214.70 to deliver 89 items including 27 types of recombinant human proteins and 12 small molecule compounds by June 30, 2021. As the sole source provider, Research and Diagnostic Systems will ship the products from its Minneapolis location within 14 days of each order to support the Center's consistent research involving cell growth and viability across projects. The non-competitive acquisition was conducted under Federal Acquisition Regulation Subpart 13.5, as re-optimization of assays would be required if an alternate supplier was used. Research and Diagnostic Systems is a division of Bio-Techne Corporation.

Generated 12/29/23, 4:23 PM